Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

[The diagnosis of prostate cancer from the clinical guidelines].

Herranz Amo F, Hernández Fernández C.

Arch Esp Urol. 2011 Oct;64(8):792-805. Review. Spanish.

PMID:
22052760
2.

Prostate cancer detection yield in repeated biopsy is independent of the diagnosis of earlier biopsies.

Grepl M, Student V, Furst T, Furstova J.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009 Dec;153(4):297-302.

3.

The value of endorectal MRI in the early diagnosis of prostate cancer.

Comet-Batlle J, Vilanova-Busquets JC, Saladié-Roig JM, Gelabert-Mas A, Barceló-Vidal C.

Eur Urol. 2003 Aug;44(2):201-7; discussion 207-8.

PMID:
12875939
4.

[Management of prostate cancer biochemical recurrence in the clinical guidelines].

Fernández CH, Patiño GE, Merino RD, Chomón GB, Rios DS, Gárate MM, Gil MJ.

Arch Esp Urol. 2012 Jan-Feb;65(1):79-83. Review. Spanish.

PMID:
22318179
5.

Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.

Guichard G, Larré S, Gallina A, Lazar A, Faucon H, Chemama S, Allory Y, Patard JJ, Vordos D, Hoznek A, Yiou R, Salomon L, Abbou CC, de la Taille A.

Eur Urol. 2007 Aug;52(2):430-5. Epub 2007 Mar 13.

PMID:
17412489
6.
7.
9.

Effect of digital rectal examination and needle biopsy on serum total and percentage of free prostate specific antigen levels.

Ornstein DK, Rao GS, Smith DS, Ratliff TL, Basler JW, Catalona WJ.

J Urol. 1997 Jan;157(1):195-8.

PMID:
8976249
10.

Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.

Mäkinen T, Tammela TL, Hakama M, Stenman UH, Rannikko S, Aro J, Juusela H, Määttänen L, Auvinen A.

J Urol. 2001 Oct;166(4):1339-42.

PMID:
11547069
11.

The prostate-specific antigen screening conundrum: examining the evidence.

O'Rourke ME.

Semin Oncol Nurs. 2011 Nov;27(4):251-9. doi: 10.1016/j.soncn.2011.07.003. Review.

PMID:
22018404
14.

A critical review of clinical practice guidelines for the management of clinically localized prostate cancer.

Dahm P, Yeung LL, Chang SS, Cookson MS.

J Urol. 2008 Aug;180(2):451-9; discussion 460. doi: 10.1016/j.juro.2008.04.004. Epub 2008 Jun 11. Review.

PMID:
18550100
15.

Clinical usefulness of free PSA in early detection of prostate cancer.

Luboldt HJ, Swoboda A, Börgermann C, Fornara P, Rübben H; Early Detection Project Group of the German Society of Urology.

Onkologie. 2001 Feb;24(1):33-7.

PMID:
11441278
16.
17.

[Summary of 'General Rule for Clinical and Pathological Studies on Prostate Cancer (the 3rd Edition)'].

Maeda O, Usami M.

Nihon Rinsho. 2005 Feb;63(2):201-6. Review. Japanese.

PMID:
15714966
18.

Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives.

Ito K.

Int J Urol. 2009 May;16(5):458-64. doi: 10.1111/j.1442-2042.2009.02293.x. Epub 2009 Apr 1. Review.

19.

Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng./ml. or less.

Carvalhal GF, Smith DS, Mager DE, Ramos C, Catalona WJ.

J Urol. 1999 Mar;161(3):835-9.

PMID:
10022696

Supplemental Content

Support Center